Evidence map›Paper›PMID 26456113›Full record

ArticleCell2015

An interbacterial NAD(P)(+) glycohydrolase toxin requires elongation factor Tu for delivery to target cells.

John C Whitney, Dennis Quentin, Shin Sawai, Michele LeRoux, Brittany N Harding, Hannah E Ledvina, Bao Q Tran, Howard Robinson, Young Ah Goo, David R Goodlett and 2 more

Open access · greenAbstract read
In one paragraph

Article in Cell, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 167 papers.

0numbers the graph read from it
0cells of the map it votes in
167citing papers in PubMed
14.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

167 citing papers in PubMed, 263 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Type VI Secretion Systems inMicroorganisms · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. The SPI-6 T6SS gene cluster fromFrontiers in microbiology · 2026
    Article
  13. Article
  14. The SPI-20 and SPI-21 T6SS gene clusters fromFrontiers in microbiology · 2026
    Article
  15. An electron transport complex required in the gut sensitizesProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  16. Article
  17. Review
  18. Review
  19. Zoological research · 2025
    Article
  20. Article

107 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

John C WhitneyDepartment of Microbiology, University of Washington, Seattle, WA 98195, USA.
Dennis QuentinDepartment of Structural Biochemistry, Max Planck Institute of Molecular Physiology, Otto-Hahn-Strasse 11, 44227 Dortmund, Germany.
Shin SawaiDepartment of Microbiology, University of Washington, Seattle, WA 98195, USA.
Michele LeRouxDepartment of Microbiology, University of Washington, Seattle, WA 98195, USA.
Brittany N HardingDepartment of Microbiology, University of Washington, Seattle, WA 98195, USA.
Hannah E LedvinaDepartment of Microbiology, University of Washington, Seattle, WA 98195, USA.
Bao Q TranDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA.
Howard RobinsonBiology Department, Brookhaven National Laboratory, Upton, NY 11973, USA.
Young Ah GooDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA.
David R GoodlettDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA.
Stefan RaunserDepartment of Structural Biochemistry, Max Planck Institute of Molecular Physiology, Otto-Hahn-Strasse 11, 44227 Dortmund, Germany.
Joseph D MougousDepartment of Microbiology, University of Washington, Seattle, WA 98195, USA; Howard Hughes Medical Institute, Seattle, WA 98195, USA. Electronic address: mougous@u.washington.edu.
University of Washington · USUniversity of Maryland, Baltimore · USMax Planck Institute of Molecular Physiology · DEBrookhaven National Laboratory · USHoward Hughes Medical Institute · US

Funding

Case Center for Synchrotron BiosciencesP30EB009998 · NIBIB · CASE WESTERN RESERVE UNIVERSITY · PI CHANCE, MARK R · 2009 to 2018
$8.4M
Type VI secretion effectors and interbacterial competition in vivoR01AI080609 · NIAID · YALE UNIVERSITY · PI MOUGOUS, JOSEPH DAVID · 2009 to 2025
$6.7M
CIHRHoward Hughes Medical InstituteNIAID NIH HHS AI080609NIAID NIH HHS R01 AI080609NIBIB NIH HHS P30 EB009998
6 · The paper itself

Abstract

Type VI secretion (T6S) influences the composition of microbial communities by catalyzing the delivery of toxins between adjacent bacterial cells. Here, we demonstrate that a T6S integral membrane toxin from Pseudomonas aeruginosa, Tse6, acts on target cells by degrading the universally essential dinucleotides NAD(+) and NADP(+). Structural analyses of Tse6 show that it resembles mono-ADP-ribosyltransferase proteins, such as diphtheria toxin, with the exception of a unique loop that both excludes proteinaceous ADP-ribose acceptors and contributes to hydrolysis. We find that entry of Tse6 into target cells requires its binding to an essential housekeeping protein, translation elongation factor Tu (EF-Tu). These proteins participate in a larger assembly that additionally directs toxin export and provides chaperone activity. Visualization of this complex by electron microscopy defines the architecture of a toxin-loaded T6S apparatus and provides mechanistic insight into intercellular membrane protein delivery between bacteria.

Indexed as

ADP Ribose TransferasesBacterial ToxinsModels, MolecularNADNAD+ NucleosidaseNADPPeptide Elongation Factor TuProtein Structure, TertiaryPseudomonas aeruginosaType VI Secretion SystemsADP Ribose TransferasesBacterial ToxinsNADNAD+ NucleosidaseNADPPeptide Elongation Factor TuType VI Secretion Systems

Identifiers

PMID26456113
PMCPMC4624332
OpenAlexW2131599797

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.